Investor

As a serial entrepreneur, Avi Lasarow has set up three successful companies in the last twenty years and is now an angel investor looking to support the next generation of healthtech start-ups.

Having completed four years from selling DNAfit to Prenetics for $10 million through to exiting in 2022, Avi is looking forward to helping more ambitious founders build disruptive technologies to help push healthcare forward and solve healthcare problems.

His insights for investment are summed up in three questions. First - does the company’s product meet a need that Avi has personally experienced?

Second, is there a founder-product-market fit, meaning does the startup have experience in its market? And third, who are the other investors and do they have a good track record in their own business or in other investments?

Early in 2023 Avi decided to provide angel investment for Floe Oral Care, which is building a groundbreaking salivary biomarker test to revolutionise how we approach dental health. He saw that the team at Floe Oral Care know their market, have a product that meets a real need, and have other top tier investors on board.